Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Aveni Foundation
xCures
Incyte Corporation
AVM Biotechnology Inc
Second Life Therapeutics